Inoviv
Inoviv is a biomarker pioneer that offers bespoke and off-the-shelf, multiplexed, fully quantitative, and validated assays using targeted proteomics. Their technology accelerates drug development pipelines by providing highly accurate, quantitative biomarker workflows and panels for pharmaceutical and biotech companies. This allows for rapid and scalable testing in various disease areas.
Buy Funded Startups lists
Funding Round:
Funding Amount:
Date: 30-Jan-2024
Investors: Hoxton Ventures, Foresight Group
Markets: Biotechnology, Pharmaceuticals, Proteomics, Biopharma, Health Care, Health Diagnostics, Medical, Medical Device, Precision Medicine, Therapeutics
HQ: London, England, United Kingdom
Founded: 2017
Website: https://www.inoviv.com/
LinkedIn: https://www.linkedin.com/company/inoviv
Twitter: https://twitter.com/InovivBio
Crunchbase: https://www.crunchbase.com/organization/inoviv
Leave a Comment
Comments
No comments yet.